Pure red cell aplasia and anti-erythropoietin antibodies in patients treated with epoetin

Nephrology Dialysis Transplantation

Volumn 18, Issue SUPPL. 8, 2003, Pages

  Casadevall, Nicole ^a  

^a HÔTEL DIEU   (France)

Author keywords

Anaemia; Anti erytropoietin antibodies; Chronic kidney disease; Pure red cell aplasia

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; HUMAN SERUM ALBUMIN; NEUTRALIZING ANTIBODY; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CHRONIC KIDNEY DISEASE; CROSS REACTION; DISEASE SEVERITY; DRUG FORMULATION; EUROPE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; PURE RED CELL ANEMIA; RETICULOCYTE COUNT;

ANTIBODIES; DRUG HYPERSENSITIVITY; ERYTHROPOIETIN, RECOMBINANT; HEMATINICS; HUMANS; RED-CELL APLASIA, PURE;

EID: 0344668586     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Krantz SB. Pure red-cell aplasia. N Engl J Med 1974; 291: 345-350
2. Peschle C, Marmont AM, Marone G, Genovese A, Sasso GF, Condorelli M. Pure red cell aplasia: studies on an IgG serum inhibitor neutralizing erythropoietin. Br J Haematol 1975; 30: 411-417
3. Jepson JH, Lowenstein L. Panhypoplasia of the bone marrow. I. Demonstration of a plasma factor with anti-erythropoietin-like activity. Can Med Assoc J 1968; 99: 99-101
4. Casadevall N, Dupuy E, Molho-Sabatier P, Tobelem G, Varet B, Mayeux P. Autoantibodies against erythropoietin in a patient with pure red-cell aplasia. N Engl J Med 1996; 334: 630-633
5. Linardaki GD, Boki KA, Fertakis A, Tzioufas AG. Pure red cell aplasia as presentation of systemic lupus erythematosus: antibodies to erythropoietin. Scand J Rheumatol 1999; 28: 189-191
6. Peces R, de la Torre M, Alcazar R, Urra JM. Antibodies against recombinant human erythropoietin in a patient with erythropoietin-resistant anemia. N Engl J Med 1996; 335: 523-524
7. Prabhakar SS, Muhlfelder T. Antibodies to recombinant human erythropoietin causing pure red cell aplasia. Clin Nephrol 1997; 47: 331-335
8. Bergrem H, Danielson BG, Eckardt KU, Kurtz A, Stridsberg M. A case of antierythropoietin antibodies following recombinant human erythropoietin treatment. In: Bauer C, Koch KM, Sciqalla P, eds. Erythropoietin: Molecular Physiology and Clinical Application. Marcel Dekker, New York, 1993; 265-275
9. Casadevall N, Nataf J, Viron B et al. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 2002; 346: 469-475
10. Sasaki H, Bothner B, Dell A, Fukuda M. Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA. J Biol Chem 1987; 262: 12059-12076
11. Skibeli V, Nissen-Lie G, Torjesen P. Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietin. Blood 2001; 98: 3626-3634
12. Casadevall N. Antibodies against rHuEPO: native and recombinant. Nephrol Dial Transplant 2002; 17 [Suppl 5]: 42-47
13. Mayeux P, Billat C, Jacquot R. The erythropoietin receptor of rat erythroid progenitor lens. Characterization and affinity cross-linkage. J Biol Chem 1987; 262: 13985-13990
14. Swissmedic Medical Update. www.swissmedic.ch/cgi/news. 25 March 2003
15. Storring PL, Tiplady RJ, Gaines Das RE et al. Epoetin alfa and beta differ in their erythropoietin isoform compositions and biological properties. Br J Haematol 1998; 100: 79-89